Overview

Study to Assess Pharmacokinetic Drug-Drug Interaction Between Avatrombopag When Co-Administered With Fluconazole, Itraconazole, or Rifampin in Healthy Subjects

Status:
Completed

Trial end date:
2016-09-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine the effects of concomitant administration with fluconazole, itraconazole, and rifampin on the pharmacokinetics (PK) of a single 20-mg dose of avatrombopag in healthy participants.

Phase:

Phase 1

Details

Lead Sponsor:

Eisai Inc.

Treatments:

Fluconazole
Hydroxyitraconazole
Itraconazole
Rifampin